Successful Control of a Co-Infection Caused by Candida albicans and Pseudomonas aeruginosa in Keratitis

Infect Disord Drug Targets. 2021;21(2):284-288. doi: 10.2174/1871526520666200318111957.

Abstract

Nowadays, the co-infection of different classes of pathogens is a major concern. The objective of this study was to develop a successful therapy for keratitis caused by the co-infection of Candida sp. with Pseudomonas sp, which is difficult to cure. The study is based on a 47 years old male farmer showing redness and watering in the right eye for 15-days. ; Methods: The microbiological examination was performed to isolate the causative organisms, i.e. Pseudomonas aeruginosa and Candida albicans. They were cultured separately along with their co-culture and treated with ciprofloxacin and amphotericin B during the growing stage to predict a definite cure. ; Results: Scanning electron microscope (SEM) results confirmed the inter-specific interaction between the two different types of microorganisms. Amphotericin-B and Ciprofloxacin showed the least MIC value for both organisms in co-culture. ; Conclusion: Treatment with Amphotericin-B and 5% ciprofloxacin effectively hindered the growth of Pseudomonas aeruginosa and Candida albicans, the co-infection of which caused keratitis. This therapy may be successfully implied for such cases of co-infection in the future.

Keywords: Amphotericin-B; Candida albicans; Pseudomonas aeruginosa.; ciprofloxacin; co-infection; keratitis.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B
  • Candida albicans
  • Coinfection*
  • Humans
  • Keratitis*
  • Male
  • Middle Aged
  • Pseudomonas aeruginosa

Substances

  • Amphotericin B